Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-026651
Filing Date
2026-06-01
Accepted
2026-06-01 16:56:00
Documents
54
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1567361
2 EX-23.1 ex23-1.htm EX-23.1 4596
3 EX-31.1 ex31-1.htm EX-31.1 20939
4 EX-32.1 ex32-1.htm EX-32.1 3382
5 GRAPHIC form10-k_001.jpg GRAPHIC 44852
6 GRAPHIC form10-k_002.jpg GRAPHIC 30865
7 GRAPHIC form10-k_003.jpg GRAPHIC 22452
8 GRAPHIC form10-k_004.jpg GRAPHIC 18936
9 GRAPHIC form10-k_005.jpg GRAPHIC 56994
10 GRAPHIC form10-k_006.jpg GRAPHIC 37155
11 GRAPHIC form10-k_007.jpg GRAPHIC 16197
  Complete submission text file 0001493152-26-026651.txt   5521904

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE glsi-20251231.xsd EX-101.SCH 24816
13 XBRL CALCULATION FILE glsi-20251231_cal.xml EX-101.CAL 27891
14 XBRL DEFINITION FILE glsi-20251231_def.xml EX-101.DEF 106878
15 XBRL LABEL FILE glsi-20251231_lab.xml EX-101.LAB 282327
16 XBRL PRESENTATION FILE glsi-20251231_pre.xml EX-101.PRE 221233
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 543961
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39555 | Film No.: 261052027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)